Earnings
📈 Stocks
Innate Pharma Extends Cash Runway to 2028 Following $75M Sobi Partnership
(just now)
Innate Pharma strengthens its balance sheet with a $75M Sobi payment and $30M equity raise, supporting a robust clinical pipeline that includes…